Clinical trials
Lymphoma, Non-Hodgkin trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 4 |
| Sun Yat-sen University | 4 |
| Timmune Biotech Inc. | 4 |
| Hebei Senlang Biotechnology Inc., Ltd. | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Fudan University | 2 |
| Henan Cancer Hospital | 2 |
| Huiqiang Huang | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Peking University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 60 |
| Recurrence | 9 |
| Lymphoma, B-Cell | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Neoplasms | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma | 2 |
| Lymphoma, T-Cell | 2 |
| Lymphoma, T-Cell, Peripheral | 2 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.